Exploratory study reveals far reaching systemic and cellular effects of verapamil treatment in subjects with type 1 diabetes

Currently, no oral medications are available for type 1 diabetes (T1D). While our recent randomized placebo-controlled T1D trial revealed that oral verapamil had short-term beneficial effects, their duration and underlying mechanisms remained elusive. Now, our global T1D serum proteomics analysis id...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Guanlan, Grimes, Tiffany D., Grayson, Truman B., Chen, Junqin, Thielen, Lance A., Tse, Hubert M., Li, Peng, Kanke, Matt, Lin, Tai-Tu, Schepmoes, Athena A., Swensen, Adam C., Petyuk, Vladislav A., Ovalle, Fernando, Sethupathy, Praveen, Qian, Wei-Jun, Shalev, Anath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894430/
https://www.ncbi.nlm.nih.gov/pubmed/35241690
http://dx.doi.org/10.1038/s41467-022-28826-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894430/
https://www.ncbi.nlm.nih.gov/pubmed/35241690
http://dx.doi.org/10.1038/s41467-022-28826-3

Ejemplares similares